Scott Dreyer - 10 Feb 2025 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Signature
/s/ Shirley R. Kuhlmann as Attorney-In-Fact For Scott Dreyer
Issuer symbol
COLL
Transactions as of
10 Feb 2025
Transactions value $
-$904,094
Form type
4
Filing time
12 Feb 2025, 16:10:22 UTC
Previous filing
28 May 2024
Next filing
10 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Award $0 +45,016 +42.51% $0 150,918 10 Feb 2025 Direct F1
transaction COLL Common Stock Award $0 +26,411 +17.5% $0 177,329 10 Feb 2025 Direct F2
transaction COLL Common Stock Tax liability -$242,725 -7,953 -4.48% $30.52 169,376 10 Feb 2025 Direct F3
transaction COLL Common Stock Tax liability -$661,368 -21,670 -12.79% $30.52 147,706 10 Feb 2025 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2026, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
F2 Effective February 10, 2025, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 26,411 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.
F3 Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.
F4 Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.